ORIC Pharmaceuticals Inc

ORIC

Company Profile

  • Business description

    ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

  • Contact

    240 E. Grand Avenue
    2nd Floor
    South San FranciscoCA94080
    USA

    T: +1 650 388-5600

    https://www.oricpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    119

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,697.50139.10-1.57%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,435.24406.38-1.78%
NASDAQ23,879.20550.69-2.25%
Nikkei 22556,967.052,477.16-4.17%
NZX 50 Index14,102.30144.95-1.02%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,597.60132.80-1.52%
SSE Composite Index3,521.4056.22-1.57%

Market Movers